PERSONALISED MEDICINES AND THE REGULATORS Dr Mike James CambReg Consulting [email protected].
May 2014 A bio-pharmaceutical company developing treatments for hypertension, diabetes, diabetic nephropathy and metabolic syndrome. 1.
Minimizing risk by optimizing clinical trial design AGAH Workshop 19 April 2008
South African Medical Research Council 2011/2012 Annual Report Presentation to the Parliamentary Portfolio Committee on Health 31 October 2012 1.
Psychopharmacology Update Kayode Giwa, PharmD, BCPP Clinical Pharmacy Specialist August 29 th, 2015.
Multi-drug resistant pathogens Helmut Albrecht, MD Division of Infectious Diseases.
PK and PD as predictors of clinical effect
Welcome to Jeopardy!
STERILFOOD TM
METHYNALTREXONE USED IN OPIOID-INDUCED URINARY RETENTION.TWO CASES REPORT
1 Minimizing risk by optimizing clinical trial design AGAH Workshop 19 April 2008 Workshop Minimizing risk by optimizing clinical trial design and performance.
